These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2290128)

  • 1. Using polymerized C9 to produce a monoclonal antibody against a neoantigen of the human terminal complement complex.
    Kusunoki Y; Takekoshi Y; Nagasawa S
    J Pharmacobiodyn; 1990 Jul; 13(7):454-60. PubMed ID: 2290128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].
    Kusunoki Y
    Hokkaido Igaku Zasshi; 1990 Jan; 65(1):74-85. PubMed ID: 2328949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma.
    Mollnes TE; Lea T; Harboe M; Tschopp J
    Scand J Immunol; 1985 Aug; 22(2):183-95. PubMed ID: 4035298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
    Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
    J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of activation of the human terminal complement pathway by ELISA.
    Sanders ME; Schmetz MA; Hammer CH; Frank MM; Joiner KA
    J Immunol Methods; 1985 Dec; 85(2):245-56. PubMed ID: 2416846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
    Kontermann R; Deppisch R; Rauterberg EW
    Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex.
    Mollnes TE; Lea T; Frøland SS; Harboe M
    Scand J Immunol; 1985 Aug; 22(2):197-202. PubMed ID: 2412280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies.
    Würzner R; Schulze M; Happe L; Franzke A; Bieber FA; Oppermann M; Götze O
    Complement Inflamm; 1991; 8(5-6):328-40. PubMed ID: 1724954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique epitope exposed in native complement component C9 and hidden in the terminal SC5b-9 complex enables selective detection and quantification of non-activated C9.
    Mollnes TE; Tschopp J
    J Immunol Methods; 1987 Jun; 100(1-2):215-21. PubMed ID: 2439601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T; Meri S
    J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against neoantigens of the terminal C5b-9 complex of human complement.
    Hugo F; Jenne D; Bhakdi S
    Biosci Rep; 1985 Aug; 5(8):649-58. PubMed ID: 2415178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement channels in membranes: inhibition with a monoclonal antibody to a neoantigen of polymerized C9.
    Dalmasso AP; Benson BA; Falk RJ
    Biochem Biophys Res Commun; 1984 Dec; 125(3):1013-9. PubMed ID: 6517929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.
    Tschopp J; Mollnes TE
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4223-7. PubMed ID: 2424021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane attack complex of complement in dermatitis herpetiformis.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    Arch Dermatol; 1985 Jan; 121(1):70-2. PubMed ID: 3881089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex.
    Hetland G; Johnson E; Falk RJ; Eskeland T
    Scand J Immunol; 1986 Oct; 24(4):421-8. PubMed ID: 3764345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement.
    Zalman LS; Müller-Eberhard HJ
    Mol Immunol; 1990 Jun; 27(6):533-7. PubMed ID: 1696352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood dendritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies.
    Würzner R; Xu H; Franzke A; Schulze M; Peters JH; Götze O
    Immunology; 1991 Sep; 74(1):132-8. PubMed ID: 1718850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement resistance in Borrelia burgdorferi strain 297: outer membrane proteins prevent MAC formation at lysis susceptible sites.
    Patarakul K; Cole MF; Hughes CA
    Microb Pathog; 1999 Jul; 27(1):25-41. PubMed ID: 10371707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular composition of the tubular structure of the membrane attack complex of complement.
    Podack ER
    J Biol Chem; 1984 Jul; 259(13):8641-7. PubMed ID: 6736043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.